WO2005067643A8 - Determination of hepatitis c virus genotype - Google Patents

Determination of hepatitis c virus genotype

Info

Publication number
WO2005067643A8
WO2005067643A8 PCT/US2005/000452 US2005000452W WO2005067643A8 WO 2005067643 A8 WO2005067643 A8 WO 2005067643A8 US 2005000452 W US2005000452 W US 2005000452W WO 2005067643 A8 WO2005067643 A8 WO 2005067643A8
Authority
WO
WIPO (PCT)
Prior art keywords
hepatitis
determination
virus genotype
methods
present
Prior art date
Application number
PCT/US2005/000452
Other languages
French (fr)
Other versions
WO2005067643A2 (en
WO2005067643A3 (en
Inventor
Vecheslav A Elagin
Scott Law
Bjork Hill
Original Assignee
Third Wave Tech Inc
Vecheslav A Elagin
Scott Law
Bjork Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Wave Tech Inc, Vecheslav A Elagin, Scott Law, Bjork Hill filed Critical Third Wave Tech Inc
Priority to CN200580007156.1A priority Critical patent/CN1977050B/en
Priority to JP2006549422A priority patent/JP5138230B2/en
Priority to EP05705217.7A priority patent/EP1716250B1/en
Priority to CA2552949A priority patent/CA2552949C/en
Publication of WO2005067643A2 publication Critical patent/WO2005067643A2/en
Publication of WO2005067643A8 publication Critical patent/WO2005067643A8/en
Publication of WO2005067643A3 publication Critical patent/WO2005067643A3/en
Priority to HK07104669.5A priority patent/HK1098512A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The present invention provides compositions and methods for the detection and characterization of HCV sequences. More particulary, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from paients, to determine HCV genotye.
PCT/US2005/000452 2004-01-07 2005-01-07 Determination of hepatitis c virus genotype WO2005067643A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN200580007156.1A CN1977050B (en) 2004-01-07 2005-01-07 Determination of hepatitis c virus genotype
JP2006549422A JP5138230B2 (en) 2004-01-07 2005-01-07 Method for determining the genotype of hepatitis C virus
EP05705217.7A EP1716250B1 (en) 2004-01-07 2005-01-07 Determination of hepatitis c virus genotype
CA2552949A CA2552949C (en) 2004-01-07 2005-01-07 Determination of hepatitis c virus genotype
HK07104669.5A HK1098512A1 (en) 2004-01-07 2007-05-02 Determination of hepatitis c virus genotype

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US53461804P 2004-01-07 2004-01-07
US60/534,618 2004-01-07
US56362904P 2004-04-20 2004-04-20
US60/563,629 2004-04-20
US11/031,487 2005-01-07

Publications (3)

Publication Number Publication Date
WO2005067643A2 WO2005067643A2 (en) 2005-07-28
WO2005067643A8 true WO2005067643A8 (en) 2005-12-01
WO2005067643A3 WO2005067643A3 (en) 2006-02-09

Family

ID=37024889

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/000452 WO2005067643A2 (en) 2004-01-07 2005-01-07 Determination of hepatitis c virus genotype

Country Status (7)

Country Link
US (2) US7473773B2 (en)
EP (1) EP1716250B1 (en)
JP (1) JP5138230B2 (en)
CN (1) CN1977050B (en)
CA (1) CA2552949C (en)
HK (1) HK1098512A1 (en)
WO (1) WO2005067643A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1977050B (en) * 2004-01-07 2012-09-05 第三次浪潮技术公司 Determination of hepatitis c virus genotype
CN101563362B (en) * 2006-08-25 2015-02-11 麦克法兰布奈特医疗研究与公共健康研究所有限公司 Recombinant HCV E2 glycoprotein
JP5041580B2 (en) * 2006-10-17 2012-10-03 一般財団法人化学及血清療法研究所 Mediating polynucleotide
WO2009117327A2 (en) 2008-03-15 2009-09-24 Hologic, Inc. Compositions and methods for analysis of nucleic acid molecules during amplification reactions
US8715937B2 (en) 2010-11-15 2014-05-06 Exact Sciences Corporation Mutation detection assay
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
MY166402A (en) * 2011-01-10 2018-06-25 The American Univ In Cairo Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles
US9303292B2 (en) 2011-01-10 2016-04-05 The American University Of Cairo Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles
WO2013116513A2 (en) * 2012-01-31 2013-08-08 American University Of Cairo (Auc) Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays & versatile and green methods forsynthesis of anisotropic silver nanostructures
WO2014158628A1 (en) 2013-03-14 2014-10-02 Hologic, Inc. Compositions and methods for analysis of nucleic acid molecules
EP3052656B1 (en) * 2013-09-30 2018-12-12 President and Fellows of Harvard College Methods of determining polymorphisms
CN103710464B (en) * 2013-12-30 2015-03-11 湖南圣维尔医学检验所有限公司 HCV (Hepatitis c virus) genotype detection kit
WO2019131592A1 (en) * 2017-12-26 2019-07-04 凸版印刷株式会社 Method for suppressing occurrence of false-negative determination in detection of target molecule, and detection device

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
JP3156200B2 (en) 1989-09-15 2001-04-16 国立予防衛生研究所長 New HCV isolate
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
WO1991014779A1 (en) 1990-03-28 1991-10-03 Mitsui Toatsu Chemicals, Incorporated Diagnostic for hepatitis virus
JPH06508026A (en) 1991-05-08 1994-09-14 カイロン　コーポレイション HCV genome sequence for diagnosis and treatment
US6190864B1 (en) * 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
DE69223562T2 (en) * 1991-08-27 1998-06-04 Hoffmann La Roche Methods and reagents for the detection of hepatitis C.
US7150982B2 (en) * 1991-09-09 2006-12-19 Third Wave Technologies, Inc. RNA detection assays
US5846717A (en) * 1996-01-24 1998-12-08 Third Wave Technologies, Inc. Detection of nucleic acid sequences by invader-directed cleavage
US5994069A (en) * 1996-01-24 1999-11-30 Third Wave Technologies, Inc. Detection of nucleic acids by multiple sequential invasive cleavages
US7045289B2 (en) * 1991-09-09 2006-05-16 Third Wave Technologies, Inc. Detection of RNA Sequences
ATE507312T1 (en) * 1992-11-27 2011-05-15 Innogenetics Nv DETECTION AND TYPING OF THE HEPATITIS C VIRUS (HCV) USING 5'UTR AND NS5 NUCLEIC ACID SEQUENCES
US5541311A (en) * 1992-12-07 1996-07-30 Third Wave Technologies, Inc. Nucleic acid encoding synthesis-deficient thermostable DNA polymerase
US5614402A (en) * 1992-12-07 1997-03-25 Third Wave Technologies, Inc. 5' nucleases derived from thermostable DNA polymerase
DE69435023T2 (en) * 1993-04-27 2008-09-11 N.V. Innogenetics S.A. SEQUENCES OF THE GENOTYPE OF HEPATITIS C-VIRUS AND THEIR USE AS MEDICAMENTS AND DIAGNOSTICS
ATE281526T1 (en) * 1993-05-05 2004-11-15 Common Services Agency HEPATITIS-C VIRUS TYPES 4.5 AND 6
SK282543B6 (en) * 1993-05-10 2002-10-08 Chiron Corporation Classification method for hepatitis c virus and agents for use in this method
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US5942391A (en) * 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
JPH10507643A (en) * 1994-10-21 1998-07-28 イノジェネティックス・ナムローゼ・フェンノートシャップ Novel sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
EP0798312B1 (en) * 1995-12-06 2003-06-18 Asahi Kasei Kabushiki Kaisha Anchor bolt fixing composition
US6090606A (en) * 1996-01-24 2000-07-18 Third Wave Technologies, Inc. Cleavage agents
US5985557A (en) * 1996-01-24 1999-11-16 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
AU731062B2 (en) 1996-01-24 2001-03-22 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
AU737449B2 (en) 1996-11-29 2001-08-23 Third Wave Technologies, Inc. FEN-1 endonucleases, mixtures and cleavage methods
US6194149B1 (en) * 1998-03-03 2001-02-27 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
JP2001523111A (en) 1997-05-05 2001-11-20 サード ウェーブ テクノロジーズ，インコーポレーテッド Target-dependent reactions using structure-bridged oligonucleotides
US6235480B1 (en) * 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
WO2001090337A2 (en) 2000-05-24 2001-11-29 Third Wave Technologies, Inc. Detection of rna
WO2001098537A2 (en) 2000-06-17 2001-12-27 Third Wave Technologies, Inc. Nucleic acid accessible hybridization sites
AU2001297524A1 (en) 2000-11-15 2002-09-19 Third Wave Technologies, Inc. Fen endonucleases
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
CN1977050B (en) 2004-01-07 2012-09-05 第三次浪潮技术公司 Determination of hepatitis c virus genotype

Also Published As

Publication number Publication date
WO2005067643A2 (en) 2005-07-28
EP1716250A2 (en) 2006-11-02
JP2007517525A (en) 2007-07-05
CN1977050A (en) 2007-06-06
US20090111092A1 (en) 2009-04-30
EP1716250B1 (en) 2015-08-05
WO2005067643A3 (en) 2006-02-09
US8071750B2 (en) 2011-12-06
CN1977050B (en) 2012-09-05
CA2552949C (en) 2012-10-02
CA2552949A1 (en) 2005-07-28
JP5138230B2 (en) 2013-02-06
US20050196750A1 (en) 2005-09-08
EP1716250A4 (en) 2009-01-21
HK1098512A1 (en) 2007-07-20
US7473773B2 (en) 2009-01-06

Similar Documents

Publication Publication Date Title
WO2005067643A3 (en) Determination of hepatitis c virus genotype
WO2005030041A3 (en) Detection of hpv
WO2008070862A3 (en) Non-invasive prenatal genetic screen
WO2007076493A8 (en) Methods and reagents for genotyping hcv
WO2007098184A3 (en) Methods and compositions for analyte detection
WO2006128138A3 (en) Biodetection by nucleic acid-templated chemistry
EP1746170A3 (en) Probes and methods for hepatitis C virus typing using multidimensional probe analysis
WO2007002463A3 (en) Methods for genotype screening using magnetic particles
WO2002090572A3 (en) Nucleic acid detection in pooled samples
WO2006078289A3 (en) Bio-barcode based detection of target analytes
WO2006086673A3 (en) Nucleotide compositions and uses thereof
WO2004027082A3 (en) Methods and compositions for detecting targets
EP2412827A3 (en) Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
WO2004036190A3 (en) Compositions and methods for detecting west nile virus
WO2004058990A3 (en) Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
DK2089343T3 (en) Click chemistry for the preparation of reporter molecules
WO2005083127A3 (en) Genetic polymorphisms associated with stroke, methods of detection and uses thereof
WO2008034110A9 (en) Use of taq polymerase mutant enzymes for dna amplification in the presence of pcr inhibitors
WO2006077102A3 (en) Method for the detection of hpv and probes, primers and kits
WO2006121888A3 (en) Methods of nucleic acid target capture
WO2005070104A3 (en) REAL-TIME POLYMERASE CHAIN REACTION-BASED GENOTYPING ASSAY FOR β2-ADRENERGIC RECEPTOR SINGLE NUCLEODITE POLYMORPHISM
WO2005003394A3 (en) Bio-barcode based detection of target analytes
WO2002034883A3 (en) A one-well assay for high throughput detection of single nucleotide polymorphisms
WO2004027081A3 (en) Methods and composition for detecting targets
ATE434622T1 (en) POLYNUCLEOTIDES FOR DETECTION AND QUANTIFICATION OF HEPATITIS B VIRUS NUCLEIC ACIDS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 29/2005 CLASSEE 30/2005 UNDER (30) REPLACE ""NOT FURNISHED"" BY ""11/031,487""

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 29/2005 CLASSEE 30/2005 UNDER (30) DELETE ""11/031,487, 7 JANUARY 2005 (07.01.2005), US""

WWE Wipo information: entry into national phase

Ref document number: 2552949

Country of ref document: CA

Ref document number: 2006549422

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2005705217

Country of ref document: EP

Ref document number: 2221/KOLNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 200580007156.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2005705217

Country of ref document: EP